High cholesterol levels accelerate the
growth of prostate tumours, research has found.
A team from Boston's Children Hospital
also found that cholesterol-lowering statin drugs may inhibit
prostate cancer growth.
The findings may help explain why prostate
cancer is more common in the West, where diets tend to be
high in cholesterol.
Details are published in the Journal of
Clinical Investigation.
Rates of prostate cancer in rural parts of China and Japan,
where low fat diets are the norm, are up to 90% less than
in the West.
Yet when Eastern men migrate to the West
their chances of being diagnosed with prostate cancer increase.
This has led doctors to suspect that environmental
factors - such as diet - may play a significant role in
the development of the disease.
Mice experiments
The Boston team injected human prostate
cancer cells into mice and watched them grow.
When the animals were fed high cholesterol
diets, cholesterol was found to accumulate in the outer
membranes of tumour cells.
This appeared to alter chemical signalling
patterns within the cells.
As a result, they resisted signals telling
them to commit suicide and instead continued to proliferate
in the uncontrolled fashion seen in cancer.
The increased cholesterol levels did not
trigger new cancers in the mice.
But six weeks after the tumour cells were
injected, mice on the high-cholesterol diets had twice as
many tumours as animals on ordinary diets.
Their tumours were also much larger in
size.
When the cells were exposed to the cholesterol-lowering
drug simvastatin, cell death increased and tumours stopped
proliferating.
But replenishing cell membranes with cholesterol
caused the cancer to run out of control again.
Lead researcher Dr Michael Freeman said:
"Our study opens up a new paradigm in thinking about how
cancer might be controlled pharmacologically by manipulating
cholesterol.
"Our data support the notion that cholesterol-lowering
drugs - which are widely used and fairly safe - might be
effective in prevention of prostate cancer, or as an adjunctive
therapy."
Chris Hiley, of the UK Prostate Cancer
Charity, said: "This research is clearly at an early stage,
as it was accomplished in mouse cells, not men, but it's
heartening to see a plausible connection made between processes
inside cells and the Westernised high fat diet that seem
to increase the risk of prostate cancer occurring.
"The results do open up thinking about
new drug therapies.
"But there is also a low tech option any
man could attempt today.
"Adopt a healthy low cholesterol diet and
active lifestyle.
"Cut down on saturated fats, reduce the
total amount of fat eaten but eat oily fish, and eat a high
fibre diet - with porridge oats, and plenty of fresh fruit
and vegetables."
Every year 27,000 men are diagnosed with
prostate cancer and 10,000 men die from it.